Newsletter | 01 February 2003 Access News 8, Focus on Access Three Years On, February 2003 HIV/AIDS RESEARCH AND DEVELOPMENT TROPICAL & NEGLECTED DISEASES VACCINES The Access Campaign three years on is addressed in this issue of AccessNews, as well as the fear of another meningitis epidemic, Roche's failing of HIV patients, fighting against neglected diseases, no agreements at Doha and HIV positive children. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefTopic overviewVideo Press release | 30 March 2006 HIV/AIDS India Patent application for AIDS drug opposed for first time in India: MSF: Patents in India endanger global access to affordable medicines and treatment scale-up Press release | 28 March 2006 HIV/AIDS As WHO and UNAIDS call for global treatment scale-up, MSF asks: where will the essential drugs come from? Press release | 15 March 2006 HIV/AIDS Access denied to crucial new HIV/AIDS medicines Statement | 09 March 2006 HIV/AIDS South Africa Getting a Crucial AIDS Drug to Southern Africa 5 min Press release | 07 February 2006 HIV/AIDS South AfricaThailand Gilead’s tenofovir ‘access program’ for developing countries: a case of false promises? Press release | 14 December 2005 HIV/AIDS Nigeria Forcing patients to pay for AIDS care endangers treatment success Press release | 08 December 2005 HIV/AIDS Intellectual property and trade AfricaSouth Africa Companies Not Selling New AIDS Drugs in Africa Press release | 07 December 2005 HIV/AIDS Intellectual property and trade Amendment to WTO trips agreement makes access to affordable medicines even more bleak Load More
Press release | 30 March 2006 HIV/AIDS India Patent application for AIDS drug opposed for first time in India: MSF: Patents in India endanger global access to affordable medicines and treatment scale-up
Press release | 28 March 2006 HIV/AIDS As WHO and UNAIDS call for global treatment scale-up, MSF asks: where will the essential drugs come from?
Press release | 07 February 2006 HIV/AIDS South AfricaThailand Gilead’s tenofovir ‘access program’ for developing countries: a case of false promises?
Press release | 14 December 2005 HIV/AIDS Nigeria Forcing patients to pay for AIDS care endangers treatment success
Press release | 08 December 2005 HIV/AIDS Intellectual property and trade AfricaSouth Africa Companies Not Selling New AIDS Drugs in Africa
Press release | 07 December 2005 HIV/AIDS Intellectual property and trade Amendment to WTO trips agreement makes access to affordable medicines even more bleak
